Niigata, Japan

Masahiko Okada

This inventor holds 1 USPTO granted patent. Top assignee: Denka Seiken Co., Ltd.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiko Okada. Retrieved from https://idiyas.com/inventor/masahiko-okada-0fupn7jo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masahiko Okada: Innovator in Cholesterol Quantification

Introduction

Masahiko Okada is a notable inventor based in Niigata, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the quantification of cholesterol levels.

Latest Patents

One of his key patents is titled "Method for quantitating cholesterol present in low density lipoproteins." This innovative method allows for the quantification of LDL cholesterol without the need for complicated centrifuge operations. The process involves a two-step approach: first, it erases cholesterol in high-density lipoprotein, very low-density lipoprotein, and chylomicron in a test sample. Second, it quantifies the cholesterol that remains in the test sample.

Career Highlights

Masahiko Okada is associated with Denka Seiken Co., Ltd., a company known for its advancements in medical technology. His work has been instrumental in improving cholesterol testing methods, which are crucial for cardiovascular health assessments.

Collaborations

He has collaborated with notable colleagues, including Hiroshi Matsui and Kazushige Mizuno, to further enhance the effectiveness of his inventions.

Conclusion

Masahiko Okada's contributions to cholesterol quantification represent a significant advancement in medical diagnostics. His innovative methods simplify the testing process, making it more accessible and efficient for healthcare providers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…